Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer
Prof Eleni Efstathiou and Prof Nick James
Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )
7 Jan 2016
Actionable targets in patients with cisplatin-resistant advanced germ cell...
Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )
7 Jan 2016
Global cancer partnership
Dr Lisa Stevens - National Cancer Institute, Washington, USA
Global cancer partnership ( Dr Lisa Stevens - National Cancer Institute, Washington, USA )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
ER and FGFR1 interaction critical in endocrine resistant breast cancer
Dr Luigi Formisano - Vanderbilt University Nashville, USA
ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )
16 Dec 2015
Interrupting breast cancer treatment for young women who desire pregnancy
Dr Olivia Pagani and Dr Ann Partridge
Interrupting breast cancer treatment for young women who desire pregnancy ( Dr Olivia Pagani and Dr Ann Partridge )
16 Dec 2015
New developments and technologies in hereditary cancer
Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...
New developments and technologies in hereditary cancer ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )
14 Dec 2015
Hormonal treatments produce similar quality of life outcomes in DCIS
Prof Patricia Ganz - UCLA, Los Angeles, USA
Hormonal treatments produce similar quality of life outcomes in DCIS ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015
Treating women with endocrine-resistant HR /HER2 advanced breast cancer
Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie...
Treating women with endocrine-resistant HR /HER2 advanced breast cancer ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
11 Dec 2015
No significant difference in recurrence rates among women with DCIS taking...
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...
No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
11 Dec 2015
Patients with DCIS receiving anastrozole reported symptoms different from those...
Prof Patricia Ganz - UCLA, Los Angeles, USA
Patients with DCIS receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life ( Prof Patricia Ganz - UCLA, Los Angeles, USA )
11 Dec 2015
Estrogen receptor mutations detected in plasma associated with worse overall...
Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA
Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer ( Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation